OBJECTIVE: The aim of this study was to determine the prevalence of the metabolic syndrome at baseline and after 6 months of lifestyle modification among obese adolescents referred to a multidisciplinary weight management program. METHODS: A total of 165 obese adolescents were evaluated at baseline, and measurements were repeated in 57 subjects who completed 6 months of the program. Metabolic syndrome was defined as having three or more of the following: a body mass index (BMI) >97(th) percentile, hypertension, low high-density lipoprotein cholesterol (HDL-C), hypertriglyceridemia, and impaired fasting glucose (IFG). RESULTS: The prevalence of a BMI >97(th) percentile, hypertension, hypertriglyceridemia, low HDL-C, and IFG was 92.7, 54.5, 29.1, 26.7, and 2.4%, respectively. The prevalence of the metabolic syndrome at baseline was 30.3%. After 6 months of lifestyle modification, BMI z scores, percent body fat, total cholesterol, and low-density lipoprotein cholesterol (LDL-C) decreased significantly from baseline; however, there was no significant change in the number of subjects demonstrating >or=three criteria of the metabolic syndrome. CONCLUSIONS: Approximately one third of the study subjects met the criteria of the metabolic syndrome, emphasizing the growing concern for the future development of premature cardiovascular disease in this high-risk population. Our data suggest that new strategies for lifestyle modification may be needed to improve cardiovascular risk factors significantly among adolescents with obesity.
OBJECTIVE: The aim of this study was to determine the prevalence of the metabolic syndrome at baseline and after 6 months of lifestyle modification among obese adolescents referred to a multidisciplinary weight management program. METHODS: A total of 165 obese adolescents were evaluated at baseline, and measurements were repeated in 57 subjects who completed 6 months of the program. Metabolic syndrome was defined as having three or more of the following: a body mass index (BMI) >97(th) percentile, hypertension, low high-density lipoprotein cholesterol (HDL-C), hypertriglyceridemia, and impaired fasting glucose (IFG). RESULTS: The prevalence of a BMI >97(th) percentile, hypertension, hypertriglyceridemia, low HDL-C, and IFG was 92.7, 54.5, 29.1, 26.7, and 2.4%, respectively. The prevalence of the metabolic syndrome at baseline was 30.3%. After 6 months of lifestyle modification, BMI z scores, percent body fat, total cholesterol, and low-density lipoprotein cholesterol (LDL-C) decreased significantly from baseline; however, there was no significant change in the number of subjects demonstrating >or=three criteria of the metabolic syndrome. CONCLUSIONS: Approximately one third of the study subjects met the criteria of the metabolic syndrome, emphasizing the growing concern for the future development of premature cardiovascular disease in this high-risk population. Our data suggest that new strategies for lifestyle modification may be needed to improve cardiovascular risk factors significantly among adolescents with obesity.
Authors: Christine L Williams; Laura L Hayman; Stephen R Daniels; Thomas N Robinson; Julia Steinberger; Stephen Paridon; Terry Bazzarre Journal: Circulation Date: 2002-07-02 Impact factor: 29.690
Authors: Phyllis W Speiser; Mary C J Rudolf; Henry Anhalt; Cecilia Camacho-Hubner; Francesco Chiarelli; Alon Eliakim; Michael Freemark; Annette Gruters; Eli Hershkovitz; Lorenzo Iughetti; Heiko Krude; Yael Latzer; Robert H Lustig; Ora Hirsch Pescovitz; Orit Pinhas-Hamiel; Alan D Rogol; Shlomit Shalitin; Charles Sultan; Daniel Stein; Pnina Vardi; George A Werther; Zvi Zadik; Nehama Zuckerman-Levin; Zeev Hochberg Journal: J Clin Endocrinol Metab Date: 2004-12-14 Impact factor: 5.958
Authors: C Invitti; C Maffeis; L Gilardini; B Pontiggia; G Mazzilli; A Girola; A Sartorio; F Morabito; G C Viberti Journal: Int J Obes (Lond) Date: 2006-04 Impact factor: 5.095
Authors: Danielle Arisa Caranti; Marco Túlio de Mello; Wagner L Prado; Lian Tock; Kãli O Siqueira; Aline de Piano; Mara C Lofrano; Dejaldo M J Cristofalo; Henrique Lederman; Sérgio Tufik; Ana R Dâmaso Journal: Metabolism Date: 2007-09 Impact factor: 8.694
Authors: Melanie K Bean; Suzanne E Mazzeo; Marilyn Stern; Ronald K Evans; Daphne Bryan; Yi Ning; Edmond P Wickham; Joseph Laver Journal: Clin Pediatr (Phila) Date: 2011-01-10 Impact factor: 1.168
Authors: Pamela Abrams; Lorraine E Levitt Katz; Reneé H Moore; Melissa S Xanthopoulos; Chanelle T Bishop-Gilyard; Thomas A Wadden; Robert I Berkowitz Journal: J Pediatr Date: 2013-05-22 Impact factor: 4.406